So excited to he featured in the Summer issue of Utah Cancer Connections magazine. Click Here to view the article with Myeloma Crowd’s Jenny Ahlstrom and Lizzy Smith talk myeloma survivorship, the chemo brain doc notes app, and more.
Jan 14, 2019
When a multiple myeloma patient achieves a negative MRD test, it doesn’t necessarily mean that the patient is cured, but it does mean that the most sensitive testing available does not detect myeloma–which is a very good thing. Dr. Gareth Morgan from the UAMS Myeloma Institute noted that this stage is “a very good endpoint…but, […]
Jan 15, 2019
As long as I have a member of the myeloma patient community there has always been discussion of the role of transplant as well as the number of transplants. Two prior studies had shown exactly opposite conclusions. Both study had differing designs, however both had elements of Velcade/Revlimid/Dex (VRD) induction, and as have previously found […]
Dec 19, 2018
Revlimid, Velcade and dexamethasone (RVD) is a standard combination for newly diagnosed patients whether they are headed to transplant or not. A study is now open using a new CD38 monoclonal antibody called Isatuximab in combination with the “standard” therapy of RVD for newly diagnosed myeloma patients who do not qualify for a bone marrow […]
Thanks to our site sponsors: